Functionalizable hydrogel microparticles of tunable size and stiffness for soft-tissue filler applications
Source abstract
Abstract
Particle size, stiffness and surface functionality are important in determining the injection site, safety and efficacy of injectable soft-tissue fillers. Methods to produce soft injectable biomaterials with controlled particle characteristics are therefore desirable. Here we report a method based on suspension photopolymerization and semi-interpenetrating network (semi-IPN) to synthesize soft, functionalizable, spherical hydrogel microparticles (MP) of independently tunable size and stiffness. MP were prepared using acrylated forms of polyethylene glycol (PEG), gelatin and hyaluronic acid. Semi-IPN MP of PEG-diacrylate and PEG were used to study the effect of process parameters on particle characteristics. The process parameters were systematically varied to produce MP with size ranging from 115 to 515μm and stiffness ranging from 190 to 1600Pa. In vitro studies showed that the MP thus prepared were cytocompatible. The ratio and identity of the polymers used to make the semi-IPN MP were varied to control their stiffness and to introduce amine groups for potential functionalization. Slow-release polymeric particles loaded with Rhodamine or dexamethasone were incorporated in the MP as a proof-of-principle of drug incorporation and release from the MP. This work has implications in preparing injectable biomaterials of natural or synthetic polymers for applications as soft-tissue fillers.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Facial Rejuvenation and Surgery Techniques · Botulinum Toxin and Related Neurological Disorders · Pickering emulsions and particle stabilization
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (58)
Show source-provided references
1. Adverse reactions to dermal fillers: review10.2310/6350.2005.31250 ↗
2. Foreign body reaction to calcium hydroxylapatite after lip augmentation10.14219/jada.archive.2007.0321 ↗
3. Risk profiles of different injectable fillers: results from the Injectable Filler Safety Study (IFS Study)
4. Current use of injectable agents for female stress urinary incontinence
5. Foreign body granuloma caused by hyaluronic acid/dextranomer microsphere filler injection10.1111/j.1365-4632.2010.04795.x ↗
6. The science of hyaluronic acid dermal fillers10.1080/14764170701774901 ↗
7. Particulate silicone for use in periurethral injections: local tissue effects and search for migration10.1016/S0022-5347(01)67398-1 ↗
8. FDA U. Guidance for industry and FDA staff vocal fold medialization devices – premarket notification [510 (k)] Submissions 2004;510.
9. Phagocytosis of different particulate dermal filler substances by human macrophages and skin cells
10. In vivo inflammatory response to polymethylmethacrylate particulate debris: effect of size, morphology, and surface area10.1002/jor.1100120111 ↗
11. Tissue response to implanted polymers: the significance of sample shape10.1002/jbm.820100308 ↗
12. Advantages of RGD peptides for directing cell association with biomaterials10.1016/j.biomaterials.2011.02.029 ↗
13. Biomaterial adherent macrophage apoptosis is increased by hydrophilic and anionic substrates in vivo10.1073/pnas.162124199 ↗
14. Surface chemistry influences implant-mediated host tissue responses10.1002/jbm.a.31649 ↗
15. Surface chemistry influences implant biocompatibility10.2174/156802608783790901 ↗
16. Surface engineering of polycaprolactone by biomacromolecules and their blood compatibility10.1177/0885328210367442 ↗
17. Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment10.1016/j.actbio.2013.03.005 ↗
18. Gel properties of hyaluronic acid dermal fillers10.1111/j.1524-4725.2012.02472.x ↗
19. Comparative physical properties of hyaluronic acid dermal fillers10.1111/j.1524-4725.2008.01046.x ↗
20. Dermal fillers
21. Hydrogel microparticles from lithographic processes: novel materials for fundamental and applied colloid science10.1016/j.cocis.2011.01.005 ↗
22. Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles10.1073/pnas.1010013108 ↗
23. Continuous-flow lithography for high-throughput microparticle synthesis10.1038/nmat1617 ↗
24. Generation of monodisperse particles by using microfluidics: control over size, shape, and composition10.1002/anie.200462226 ↗
25. Squishy non-spherical hydrogel microparticles10.1002/marc.200900302 ↗
26. The hydrogel template method for fabrication of homogeneous nano/microparticles10.1016/j.jconrel.2009.09.032 ↗
27. Fabrication and characterization of cross-linkable hydrogel particles based on hyaluronic acid: potential application in vocal fold regeneration10.1163/156856208783432462 ↗
28. Synthesis and characterization of photo-cross-linked networks based on l-lactide/serine copolymers10.1021/ma981729j ↗
29. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery10.1016/j.ijpharm.2006.05.050 ↗
30. Influence of the geometric factors of the experimental device used in suspension polymerization on the properties of poly(styrene-co-divinylbenzene) microparticles10.1002/app.35129 ↗
31. Cytocompatibility of UV and visible light photoinitiating systems on cultured NIH/3T3 fibroblasts in vitro10.1163/156856200743805 ↗
32. Photoinitiated polymerization of PEG-diacrylate with lithium phenyl-2,4,6-trimethylbenzoylphosphinate: polymerization rate and cytocompatibility10.1016/j.biomaterials.2009.08.055 ↗
33. Variable cytocompatibility of six cell lines with photoinitiators used for polymerizing hydrogels and cell encapsulation10.1016/j.biomaterials.2004.04.024 ↗
34. Stop-flow lithography to generate cell-laden microgel particles10.1039/b804234a ↗
35. Human cartilage repair with a photoreactive adhesive-hydrogel composite10.1126/scitranslmed.3004838 ↗
36. ICRS 2013 press release. Hydrogel Implant GelrinC Demonstrates Impressive Recovery Rates for Patients with Knee Cartilage Damage. http://www.regentis.co.il/files/files/ICRS%202013%20press%20release.pdf.
37. Structural and rheological properties of methacrylamide modified gelatin hydrogels10.1021/bm990017d ↗
38. Hydrogel surfaces to promote attachment and spreading of endothelial progenitor cells10.1002/term.517 ↗
39. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery10.1016/j.biomaterials.2005.12.021 ↗
40. A dexamethasone-loaded PLGA microspheres/collagen scaffold composite for implantable glucose sensors10.1002/jbm.a.32512 ↗
41. Determination of free amino groups in proteins by trinitrobenzenesulfonic acid10.1016/0003-2697(66)90275-2 ↗
42. An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines10.1016/0003-2697(75)90431-5 ↗
43. Shear thickening in densely packed suspensions of spheres and rods confined to few layers10.1122/1.3474580 ↗
44. Does size matter? Elasticity of compressed suspensions of colloidal- and granular-scale microgels10.1039/C1SM06355C ↗
45. Polymeric microspheres for medical applications10.3390/ma3063537 ↗
46. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles10.1016/j.ijpharm.2008.04.042 ↗
47. Comparison of the rheological properties of viscosity and elasticity in two categories of soft tissue fillers: calcium hydroxylapatite and hyaluronic acid10.1111/j.1524-4725.2010.01743.x ↗
48. Synthesis and RGD peptide modification of a new biodegradable copolymer – poly(lactic acid-co-lysine)10.1021/ja00076a077 ↗
49. Protein functionalized micro hydrogel features for cell–surface interaction10.1007/s10544-008-9167-6 ↗
50. Epithelialization of hydrogels achieved by amine functionalization and co-culture with stromal cells10.1016/j.biomaterials.2007.08.028 ↗
51. Radio-opaque and surface-functionalized polymer microparticles: potentially safer biomaterials for different injection therapies10.1021/bm0603903 ↗
52. Alginate hydrogels as synthetic extracellular matrix materials10.1016/S0142-9612(98)00107-0 ↗
53. ASDS guidelines of care: injectable fillers
54. Precise control of PLG microsphere size provides enhanced control of drug release rate10.1016/S0168-3659(02)00136-0 ↗
55. Suspension polymerization processes10.1002/ceat.201000210 ↗
56. Synthesis of monodisperse polymer microspheres by photopolymerization of microdroplets10.1007/s00396-006-1625-1 ↗
57. Production of porous suspension polymers using a continuous tubular reactor10.1007/s003960050523 ↗
58. Suspension, emulsion and dispersion polymerization – a methodological survey10.1007/BF00776142 ↗